Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I–II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database
European Journal of Cancer, 06/25/09
Mandalà M et al. - In a trial to investigate if the tumour infiltrating lymphocytes (TILs) are able to predict sentinel lymph node (SLN) positivity, disease-free survival (DFS), and overall survival (OS) in clinical stages I-II AJCC primary cutaneous melanoma (PCM), this study demonstrates that absence of TILs predicts SLN metastasis, in multivariate analysis the SLN positivity predicts DFS and OS.
Methods- The study included consecutive pts with PCM, all diagnosed, treated, and followed up prospectively.
- Logistic regression was used to investigate the association between DFS, OS, SLN positivity, and Breslow thickness, Clark level, TIL, ulceration, lesion site, gender, regression and age.
- 1251 consecutive pts with PCM were evaluated.
- Median age was 51 with 32.2% (n = 393) of them older than 60; 44.8% of them were males.
- Of the whole series, 404 pts with primary vertical growth phase (VGP) melanoma and no clinical evidence of metastatic disease underwent SLN biopsy.
- Of these, 74 (18.8%) had a positive SLN.
- In multivariate analysis, primary melanoma on the extremities vs that on the axial locations (truncal and head/neck) and TILs (TILs vs no TILs) were predictive for lower probability of SLN involvement, while thickness (>4 mm vs 0–1 mm) was predictive for higher risk of SLN positivity.
- A multivariate stepwise analysis confirmed these results.
- The histological status of the SLN was the most significant predictor of DFS and OS.
- Pts with a negative SLN had a 5-yr DFS of 75.9%, compared with 35.2% in pts with a positive SLN and a 5-yr OS of 88.7% vs 42.9%, respectively.
Related Articles
Functional implication of Netrin expression in malignant melanoma
Cellular Oncology, 12/08/09
Relevance Score: 92%
Dormancy of metastatic melanoma
Pigment Cell & Melanoma Research, 11/11/09
Relevance Score: 91%
ADAM10 Is Upregulated in Melanoma Metastasis Compared with Primary Melanoma
Journal of Investigative Dermatology, 11/03/09
Relevance Score: 91%
Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression
Modern Pathology, 11/11/09
Relevance Score: 90%
Distinct MHC gene expression patterns during progression of melanoma
Genes, Chromosomes and Cancer, 11/02/09
Relevance Score: 90%
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions
Human Pathology, 12/19/09
Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays
Human Pathology, 12/19/09
Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center
Leukemia and Lymphoma, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


